CircRNA Synthesis Market is becoming an increasingly significant field of RNA technology as more and more scientists and pharmaceutical companies are now looking at circular RNA for its applications in gene regulation, biomarker discovery, drug discovery, and therapy. The unique feature of circular RNA compared to linear RNA is the covalent bond in the circular RNA, which makes the molecule more stable and resistant to the action of exonucleases.
The CircRNA Synthesis Market has been valued at USD 183.58 million in 2024 and will reach a value of USD 592.84 million by 2032, registering a CAGR of 15.85% between 2025 and 2032. Growth drivers include advancements in RNA synthesis technologies, investments in RNA based drug discovery and research in areas such as oncology, neurological diseases, rare diseases and precision medicine. Advancements in RNA sequencing, synthetic biology, enzymatic ligation, rolling circle transcription, automation and sequence optimization are enabling researchers to synthesize circRNA more efficiently, stably and functionally consistent.
Gain More Information on CircRNA Synthesis Market – Request Free Sample Report
Top 4 CircRNA Synthesis Companies
1. GenScript
GenScript is one of the leading firms in life sciences that caters to the increasing need for customized RNA synthesis and other services. Its increasing expertise in in vitro transcription and circular RNA synthesis enables scientists to examine the properties and uses of circRNAs and delivery systems. This is especially important in the current scenario where pharma and biotech companies tend to contract out some of their RNA synthesis services to experts in the field. In September 2023, GenScript improved its mRNA IVT synthesis platform by providing custom circRNA synthesis and lipid nanoparticle formulation services.
2. Thermo Fisher Scientific
Thermo Fisher Scientific has an excellent standing in the area of RNA research due to its comprehensive range of molecular biology reagents, nucleic acids technologies, sequencing instruments, and laboratory solutions. Thermo Fisher Scientific can be considered an appropriate player when it comes to the studies in circRNA synthesis, characterization, sequencing, and function. In addition, the extensive research base of the company will help to take advantage of the growth in popularity of circRNA in drug development and biomarkers identification.
3. Creative Biogene
Creative Biogene is expanding its footprint in the circRNA research market by providing custom RNA synthesis and biotech services suitable for academic and pharmaceutical use. These services are meant to help scientists study circRNA biology and function in areas such as circRNA function, circRNA expression, circRNA mechanism and circRNA therapy. The company is gaining from increased outsourcing of research services as circRNA research becomes increasingly challenging and necessitates advanced techniques in RNA synthesis, RNA purification, sequencing and bioinformatics.
4. OriGene Technologies
OriGene Technologies contributes to the growing market of CircRNA Synthesis Market by offering the services of gene synthesis and custom cloning and molecular biology, which offer important tools for the study of RNA and gene function. The company provides custom gene synthesis and cloning services along with an array of research reagents, which are used by academic, pharmaceutical, and biotechnology companies. The company’s capacity allows performing the research in circRNA on the upstream level through sequence creation and molecular testing as the need for customized RNA research increases.
What is Driving the Future of the CircRNA Synthesis Market?
Rising popularity of RNA therapies is one of the major factors influencing the CircRNA Synthesis Market. There are various properties that set apart circRNAs from regular linear RNA molecules, such as increased stability and protection against degradation. Additionally, their capability of acting as templates for proteins as well as regulating genes makes them ideal candidates for application in therapy, vaccination, gene therapy, and protein replacement. Preclinical studies are expanding; hence, there is an increasing need for reliable circRNA synthesis technologies.
Progress in RNA synthesis technologies is contributing significantly to the market expansion. Enzymatic synthesis technologies, such as ligation, and exon-intron permuting technologies allow scientists to synthesize circular RNAs effectively and maintain the integrity of the synthesized molecule. Rolling circle transcription is also considered as an option for high-throughput RNA synthesis. This is promoting the synthesis efficiency, purity, and scalability, which can be used for academic research and drug discovery purposes. Another factor that contributes to the market growth is the widespread application of next generation sequencing and transcriptomics techniques. It allows scientists to find, characterize, and study circRNA expression profiles more accurately, thus generating numerous opportunities in biomarker discovery and disease studies.
Although there is high growth potential in the market, there is an obstacle that comes from the lack of standardized procedures and techniques. Scientists utilize different methods for purification, quantification, enrichment, and validation of circRNAs, which include RNase R depletion, divergent primers quantitative PCR, and RNA sequencing technique. This variation in methods may cause inconsistency, and thus, the development of standardized quality control measures would be crucial for the transition of the circRNA technology from scientific application to regulation.
The Road Ahead
Future trends for the CircRNA Synthesis Market would include the evolution of the use of circular RNA from emerging field of study into its practical application as therapeutic, diagnostics and drug discovery tool. The use of pharmaceuticals and biotech companies is anticipated to continue being the primary end-users due to rising number of studies related to RNA drugs development in the field of oncology, neurology, cardiovascular disorders, orphan diseases, vaccines, and precision medicine. Stability of circRNA versus linear RNA as well as protein expression capacity makes the emergence of circRNA-based therapeutic studies possible. Rising studies of circRNA-based biomarkers are also anticipated to open up avenues for the application of circRNA in diagnostics of diseases and treatment monitoring.
The services are forecasted to receive immense traction as the study of circRNAs becomes more specialized. Synthesis, sequencing, purification, validation, and bioinformatics outsourcing services may simplify operations and expedite research processes for pharmaceutical companies, biotechnology companies, and academic organizations. Such a move will open up many opportunities for the companies providing end-to-end circRNA development solutions, which will include sequence design, synthesis optimization, analytics, and validation. The importance of standardization protocols for synthesis, purification, quantification, and assessment of quality will become more evident as the circRNA applications are developed for clinical use.
